Corinne Jenkins
Stock Analyst at Goldman Sachs
(1.83)
# 3,206
Out of 5,182 analysts
58
Total ratings
43.9%
Success rate
-0.55%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Corinne Jenkins
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ROIV Roivant Sciences | Maintains: Buy | $24 → $33 | $28.17 | +17.15% | 7 | Dec 15, 2025 | |
| RYTM Rhythm Pharmaceuticals | Maintains: Buy | $141 → $157 | $85.48 | +83.67% | 11 | Dec 12, 2025 | |
| IDYA IDEAYA Biosciences | Maintains: Neutral | $27 → $30 | $30.96 | -3.10% | 6 | Oct 21, 2025 | |
| GERN Geron | Reinstates: Sell | $1 | $1.71 | -41.52% | 4 | Jul 10, 2025 | |
| TGTX TG Therapeutics | Maintains: Neutral | $20 → $22 | $34.21 | -35.69% | 8 | Nov 5, 2024 | |
| FULC Fulcrum Therapeutics | Upgrades: Buy | $6 → $15 | $7.90 | +89.87% | 2 | May 14, 2024 | |
| ALT Altimmune | Reinstates: Neutral | $13 | $3.37 | +285.76% | 3 | Jan 24, 2024 | |
| HRMY Harmony Biosciences Holdings | Maintains: Sell | $25 → $28 | $28.47 | -1.65% | 7 | Jan 9, 2024 | |
| BTAI BioXcel Therapeutics | Maintains: Neutral | $192 → $64 | $1.10 | +5,718.18% | 6 | Aug 15, 2023 | |
| ACRS Aclaris Therapeutics | Maintains: Buy | $25 → $21 | $3.95 | +431.65% | 2 | Mar 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $9 → $14 | $52.66 | -73.41% | 2 | Dec 20, 2022 |
Roivant Sciences
Dec 15, 2025
Maintains: Buy
Price Target: $24 → $33
Current: $28.17
Upside: +17.15%
Rhythm Pharmaceuticals
Dec 12, 2025
Maintains: Buy
Price Target: $141 → $157
Current: $85.48
Upside: +83.67%
IDEAYA Biosciences
Oct 21, 2025
Maintains: Neutral
Price Target: $27 → $30
Current: $30.96
Upside: -3.10%
Geron
Jul 10, 2025
Reinstates: Sell
Price Target: $1
Current: $1.71
Upside: -41.52%
TG Therapeutics
Nov 5, 2024
Maintains: Neutral
Price Target: $20 → $22
Current: $34.21
Upside: -35.69%
Fulcrum Therapeutics
May 14, 2024
Upgrades: Buy
Price Target: $6 → $15
Current: $7.90
Upside: +89.87%
Altimmune
Jan 24, 2024
Reinstates: Neutral
Price Target: $13
Current: $3.37
Upside: +285.76%
Harmony Biosciences Holdings
Jan 9, 2024
Maintains: Sell
Price Target: $25 → $28
Current: $28.47
Upside: -1.65%
BioXcel Therapeutics
Aug 15, 2023
Maintains: Neutral
Price Target: $192 → $64
Current: $1.10
Upside: +5,718.18%
Aclaris Therapeutics
Mar 7, 2023
Maintains: Buy
Price Target: $25 → $21
Current: $3.95
Upside: +431.65%
Dec 20, 2022
Maintains: Buy
Price Target: $9 → $14
Current: $52.66
Upside: -73.41%